Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.32 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12355664 | 0.89 | CA2 (0.43) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL11954818 | 0.87 | GABRA1 (0.50) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL6783300 | 0.85 | CA2 (0.40) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL20268797 | 0.81 | CA2 (0.44) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL8599850 | 0.81 | CA2 (0.44) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL180679 | 0.80 | CA2 (0.43) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL11884979 | 0.80 | CA2 (0.41) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL28214308 | 0.80 | ALOX12 (0.38) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL332092 | 0.79 | ALDH1A1 (0.44) | CA2ALDH1A1TDP1KDM4ENR1H4 | |
| SCHEMBL1405888 | 0.78 | ALDH1A1 (0.42) | CA2ALDH1A1TDP1KDM4ENR1H4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2683749-B1 | ALUMINOXANE CATALYST ACTIVATORS CONTAINING CARBOCATION AGENTS, AND USE THEREOF IN POLYOLEFIN CATALYSTS | GRACE W R & CO (US) | 2023-06-07 | — | — | EP | claimed |
| CN-103534278-B | Aluminoxane catalyst activators containing carbocationic agents and their use in polyolefin catalysts | 阿尔比马尔公司 | 2016-10-05 | — | — | CN | claimed |
| US-9090720-B2 | Aluminoxane catalyst activators containing carbocation agents, and use thereof in polyolefin catalysts | ALBEMARLE CORPORATION (US) | 2015-07-28 | — | — | US | claimed |
| CN-103534278-A | Aluminoxane catalyst activators containing carbocationic agents and their use in polyolefin catalysts | ALBEMARLE CORP | 2014-01-22 | — | — | CN | claimed |
| EP-2683749-A1 | ALUMINOXANE CATALYST ACTIVATORS CONTAINING CARBOCATION AGENTS, AND USE THEREOF IN POLYOLEFIN CATALYSTS | Albemarle Corporation (US) | 2014-01-15 | — | — | EP | claimed |
| US-20130345376-A1 | Aluminoxane Catalyst Activators Containing Carbocation Agents, and use thereof in Polyolefin Catalysts | ALBEMARLE CORPORATION (US) | 2013-12-26 | — | — | US | claimed |
| WO-2012122332-A1 | ALUMINOXANE CATALYST ACTIVATORS CONTAINING CARBOCATION AGENTS, AND USE THEREOF IN POLYOLEFIN CATALYSTS | ALBEMARLE CORPORATION (US) | 2012-09-13 | — | — | WO | claimed |
| US-20240228682-A1 | POLYETHYLENE COPOLYMER WITH BROAD SHORT CHAIN BRANCHING DISTRIBUTION | W.R. GRACE & CO.-CONN. (US) | 2024-07-11 | — | — | US | disclosed |
| CN-118005533-A | Preparation method of chiral cyano amine derivative | 西湖大学 | 2024-05-10 | — | — | CN | disclosed |
| EP-4337703-A1 | POLYETHYLENE COPOLYMER WITH BROAD SHORT CHAIN BRANCHING DISTRIBUTION | W. R. Grace & Co.-Conn (US) | 2024-03-20 | — | — | EP | disclosed |
| CN-117616055-A | Polyethylene copolymers with broad short chain branching distribution | 格雷斯公司 | 2024-02-27 | — | — | CN | disclosed |
| EP-2683749-B1 | ALUMINOXANE CATALYST ACTIVATORS CONTAINING CARBOCATION AGENTS, AND USE THEREOF IN POLYOLEFIN CATALYSTS | GRACE W R & CO (US) | 2023-06-07 | — | — | EP | disclosed |
| WO-2022241225-A1 | POLYETHYLENE COPOLYMER WITH BROAD SHORT CHAIN BRANCHING DISTRIBUTION | W.R. GRACE & CO.-CONN. (US) | 2022-11-17 | — | — | WO | disclosed |
| US-20200247826-A1 | COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME, BACKLIGHT UNIT, AND DISPLAY DEVICE | LG CHEM, LTD. (KR) | 2020-08-06 | — | — | US | disclosed |
| CN-103534278-B | Aluminoxane catalyst activators containing carbocationic agents and their use in polyolefin catalysts | 阿尔比马尔公司 | 2016-10-05 | — | — | CN | disclosed |
| US-9090720-B2 | Aluminoxane catalyst activators containing carbocation agents, and use thereof in polyolefin catalysts | ALBEMARLE CORPORATION (US) | 2015-07-28 | — | — | US | disclosed |
| EP-2683749-A1 | ALUMINOXANE CATALYST ACTIVATORS CONTAINING CARBOCATION AGENTS, AND USE THEREOF IN POLYOLEFIN CATALYSTS | Albemarle Corporation (US) | 2014-01-15 | — | — | EP | disclosed |
| US-20130345376-A1 | Aluminoxane Catalyst Activators Containing Carbocation Agents, and use thereof in Polyolefin Catalysts | ALBEMARLE CORPORATION (US) | 2013-12-26 | — | — | US | disclosed |
| WO-2012122332-A1 | ALUMINOXANE CATALYST ACTIVATORS CONTAINING CARBOCATION AGENTS, AND USE THEREOF IN POLYOLEFIN CATALYSTS | ALBEMARLE CORPORATION (US) | 2012-09-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200247826-A1 | COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME, BACKLIGHT UNIT, AND DISPLAY DEVICE | UROD, ALDH1A2, UBE2I | CA2 4695/4885GABRA1 1918/4885GABRB2 2464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.